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Roles of Aquaporin-3 in the Epidermis
Mariko Hara-Chikuma1,2 and A.S. Verkman1
Aquaporin-3 (AQP3) is a membrane transporter of
water and glycerol expressed in plasma membranes in
the basal layer keratinocytes of epidermis in normal
skin. AQP3 expression in human skin is increased in
response to skin stress in diseases such as atopic
eczema, to various agents such as retinoic acid, and in
skin carcinomas. AQP3-knockout mice have reduced
stratum corneum water content and elasticity com-
pared with wild-type mice, as well as impaired
wound healing and epidermal biosynthesis. Reduced
AQP3-dependent glycerol transport in AQP3-deficient
epidermis appears to be responsible for these
phenotype findings, as evidenced by reduced glycerol
content in epidermis and stratum corneum in AQP3-
knockout mice, and correction of the phenotype
abnormalities by glycerol replacement. Recent data
implicate AQP3 as an important determinant in
epidermal proliferation and skin tumorigenesis, in
which AQP3-knockout mice are resistant to tumor
formation by a mechanism that may involve reduced
cell glycerol content and ATP energy for biosynthesis.
AQP3 is thus a key player in epidermal biology and a
potential target for drug development.
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INTRODUCTION
The aquaporins (AQPs) are a family of small, hydrophobic,
integral membrane proteins that act primarily as water-
selective pores, facilitating osmotically driven water transport
across cell plasma membranes. There are at least 13
mammalian AQPs (AQP0–AQP12), which have been divided
into two groups on the basis of their permeability. AQPs 1, 2,
4, 5, and 8 function primarily as water-selective transporters;
AQPs 3, 7, 9, and 10, termed ‘‘aquaglyceroporins’’, transport
water as well as glycerol and possibly other small solutes. The
AQPs are expressed in plasma membranes in a variety of cell
types, where they function as pore-like passive transporters
responding to transmembrane osmotic gradients (for water
transport) or glycerol gradients (for glycerol transport).
Phenotype analysis of transgenic mice lacking individual
AQPs has revealed multiple physiological roles of AQPs
(reviewed by Verkman, 2005). AQP-facilitated water trans-
port is involved in the urinary concentration mechanism,
epithelial fluid secretion, brain edema, neural signal trans-
duction, and cell migration. AQPs in epithelia facilitate
transepithelial water transport in response to osmotic
gradients, such as fluid absorption by kidney proximal tubule
(Schnermann et al., 1998) and fluid secretion in salivary
gland (Ma et al., 1999). AQPs in microvascular endothelia
and other cell types facilitate cell migration by enhancing
water transport into lamellipodia at the leading edge of
migrating cells (Saadoun et al., 2005a). In contrast, the
aquaglyceroporins are involved in metabolic pathways,
such as adipose AQP7 in obesity (Hara-Chikuma et al.,
2005; Hibuse et al., 2005), and AQP9 in glycerol metabolism
(Liu et al., 2007; Rojek et al., 2007).
This review focuses on the experimental evidence for the
involvement of AQP3-facilitated water and glycerol transport
in skin physiology. AQP expression in skin is reviewed,
followed by evidence, largely from phenotype analysis of
AQP3-knockout mice, for involvement of AQP3 in skin
hydration, wound healing, and tumorigenesis.
AQP EXPRESSION IN SKIN
Several AQPs have been reported to be expressed in various
cell types in mammalian skin, providing indirect evidence for
their involvement in some of the functions mentioned above.
AQP3, the most studied and well-validated AQP in skin, was
first reported in keratinocytes of rat epidermis (Frigeri et al.,
1995) after its cloning from rat kidney in 1994 by several
laboratories (Echevarria et al., 1994; Ishibashi et al., 1994;
Ma et al., 1994). AQP3 expression in plasma membranes in
the basal layer of keratinocytes was also detected in human
and mouse skin (Sugiyama et al., 2001; Ma et al., 2002;
Sougrat et al., 2002). Figure 1a shows AQP3 immunofluor-
escence in the basal layer of keratinocytes in mouse skin.
Expression of AQP9 was also reported in cultures of human
differentiated keratinocytes (Sugiyama et al., 2001) and in the
stratum granulosum layer of mouse epidermis (Rojek et al.,
2007), and expression of AQP10 was reported by reverse
transcriptase-PCR in human keratinocyte cultures (Boury-
Jamot et al., 2006).
AQP1 is expressed in endothelial cells throughout micro-
vessels outside of the central nervous system, such as in the
kidney, lung, secretory glands, skeletal muscle, pleura, and
peritoneum (Nielsen et al., 1993; Hasegawa et al., 1994). In
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skin, AQP1 expression was found by immunocytochemistry
in rat dermal capillaries (Agren et al., 2003) and human
neonatal dermis (Marchini et al., 2003). AQP1 is also
expressed in microvessels in tumors implanted in skin, where
as mentioned above it is involved in tumor angiogenesis
(Saadoun et al., 2005a). Whether AQP1 is functionally
important in normal skin functions is unknown.
AQP5 is expressed in sweat glands in humans, rat, and
mice (Nejsum et al., 2002; Song et al., 2002). AQP5 deletion
in mice did not, by multiple measurement methods, affect
sweat secretion (Song et al., 2002). However, whether AQP5
is important in sweat secretion in humans is not known, as
there are notable differences in sweat gland physiology
between rodents and humans. As mentioned above, AQP7 is
expressed in the adipocytes in subcutaneous tissue. AQP7-
knockout mice manifest progressive adipocyte hypertrophy
as a consequence of reduced AQP7-facilitated plasma
membrane glycerol exit in adipocytes. AQP7 is thus likely
involved in hypertrophy of adipocytes in hypodermis.
Regarding other cell types in skin, AQP3 was found to be
expressed in sebaceous glands (Frigeri et al., 1995). Recent
reverse transcriptase-PCR analysis of human primary skin
cultures showed expression of AQP1 in melanocytes and
fibroblasts, and of AQP3 and AQP9 in Langerhans cells using
monocyte-derived dendritic cells (Boury-Jamot et al., 2006).
However, significance of these observations is unknown.
FUNCTIONS OF AQP3 IN KERATINOCYTES
Skin hydration
The most superficial layer of skin is the stratum corneum (SC),
which consists of terminally differentiated keratinocytes that
originate from actively proliferating keratinocytes in the
lower epidermis and contain a lipid extracellular matrix
secreted from lamellar bodies (Elias, 2005). Hydration of the
SC is an important determinant of skin appearance and
physical properties, and depends on a number of factors,
including external humidity; and its structure, lipid/protein
composition, barrier properties, and concentration of water-
retaining osmolytes; or ‘‘natural moisturizing factors’’ such as
free amino acids, ions, and other small solutes (Rawlings and
Matts, 2005). Reduced SC hydration is found in aged skin and
in skin diseases including atopic dermatitis, eczema, psori-
asis, senile xerosis, and hereditary ichthyosis (Tagami et al.,
2001; Chuong et al., 2002).
Compared with wild-type mice, the skin of AQP3-null
mice, as examined in a hairless, SKH1 genetic background, is
relatively dry, rough, and aged. SC hydration, as measured by
high-frequency skin conductance (Figure 1b, top) and 3H2O
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Figure 1. Reduced SC hydration and glycerol content in AQP3-null mice. (a) Immunofluorescence showing AQP3 staining in mouse epidermal cells.
E, epidermis; D, dermis; sc, stratum corneum. (b) (Top) High-frequency superficial skin surface conductance in dorsal skin of hairless wild-type (þ /þ )
and AQP3-null (/) mice (SEM, n¼20, *Po0.001). (Bottom) Skin elasticity measured in dorsal skin using a 2-mm diameter suction probe and 50 mbar
pressure transient (SEM, n¼ 7, *Po0.01). (c) Glycerol content in the SC and epidermis (SEM, n¼ 5–6, *Po0.01). (d) Correlation between SC glycerol
content and skin conductance for wild-type (filled circles) and AQP3-null (open circles) mice in a 90% atmosphere. Glycerol was administered orally.
Adapted with permission from Ma et al. (2002), Hara et al. (2002), and Hara and Verkman (2003).
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partitioning (not shown), was significantly reduced in AQP3-
null mice, as was skin elasticity as measured by displacement
ratio following pulsed suction (Figure 1b, bottom) (Ma et al.,
2002). A series of experiments were performed to investigate
the mechanism by which AQP3 deficiency reduces SC
hydration. Remarkably, exposure of mice to high humidity
or skin occlusion increased SC hydration in the wild type, but
not in AQP3-null mice, suggesting an intrinsic defect in
water-holding capacity, as verified by sorption–desorption
measurements (Ma et al., 2002). The inability of high
humidity or occlusion to correct reduced SC hydration also
provides evidence against involvement of AQP3-facilitated
water permeability in SC hydration, which is not unexpected,
as water movement into the SC to offset evaporative water
losses is many orders of magnitudes slower than that where
AQPs are involved.
A systematic analysis of epidermis and SC in AQP3-
deficient mice revealed reduced glycerol content in SC and
epidermis compared with wild-type mice (Figure 1c), with
normal glycerol content in dermis and serum. No significant
differences were found in wild-type versus AQP3-deficient
mice regarding SC structure, lipid profile, protein content,
and the concentrations of amino acids, ions, and other small
solutes (Hara et al., 2002). As expected, water and glycerol
permeabilities were reduced in AQP3-null keratinocytes.
Reduced glycerol transport from blood into the epidermis and
SC through the relatively glycerol-impermeable basal kerati-
nocyte layer was found, which accounted for the reduced
steady-state epidermal and SC glycerol content (Hara and
Verkman, 2003). SC glycerol is also derived from sebaceous
glands where AQP3 is expressed (Fluhr et al., 2003). Further
studies are needed to determine whether AQP3 facilitates
secretion of glycerol by sebaceous glands, as well as the
relative contributions of epidermis versus sebaceous glands
to SC glycerol.
As further evidence that reduced epidermal and SC
glycerol content was responsible for the decreased hydration
and elasticity in AQP3-null mice, SC glycerol content and
hydration were correlated in wild-type and AQP3-null mice
in which SC glycerol content was varied by systemic glycerol
administration (Hara and Verkman, 2003). Figure 1d shows
strong correlation between SC water content, as assessed by
skin conductance, and SC glycerol content in mice placed in
a 90% humidity atmosphere and given oral glycerol. Oral
glycerol administration also corrected the reduced skin
elasticity in AQP3 null mice.
These results implicated an important role for AQP3-
facilitated glycerol transport in regulating SC and epidermal
glycerol content, and for glycerol as a key determinant of skin
hydration. These findings also provided a rational scientific
basis for the longstanding practice of including glycerol in
cosmetic and skin medicinal preparations.
Wound healing
Cutaneous wound healing is a multi-step process that
involves several cell types, including epidermal keratino-
cytes, fibroblasts, endothelial cells, and peripheral nerve
cells. Re-epithelialization is a crucial step during wound
healing, which involves migration and proliferation of
keratinocytes from the surrounding epidermis and appen-
dages such as hair follicles and sweat glands (Martin, 1997;
Hunt et al., 2000). Our initial study found delayed healing of
cutaneous wounds in AQP3-null mice (Figure 2a; Hara et al.,
2002). More recent studies have established the likely
mechanisms for this phenotype: reduced AQP3-facilitated
water transport in keratinocytes from AQP3-null mice,
resulting in impaired keratinocyte migration, and reduced
AQP3-facilitated glycerol transport, resulting in impaired
AQP3-facilitated proliferation.
The motivation for studying AQP3-facilitated migration of
keratinocytes was our earlier observation of defective
angiogenesis and endothelial cell migration in AQP1
deficiency (Saadoun et al., 2005a), and follow-up findings
of defective astroglial cell migration in AQP4 deficiency
(Saadoun et al., 2005b; Auguste et al., 2007) and defective
migration of kidney proximal tubules cells in AQP1
deficiency (Hara-Chikuma and Verkman, 2006). Migration
measurements using transwell assay, in which cell migration
through a porous filter is measured in response to a
chemotactic stimulus, showed impaired migration in AQP3-
knockdown (small interfering RNA) human keratinocyte
cultures and AQP3-knockout mouse keratinocyte cultures
(Hara-Chikuma and Verkman, 2008a; Figure 2b). Both AQP3
and AQP1 (a water-only AQP) adenoviral infection corrected
the migration defect and restored cell membrane water
permeability. In an in vitro scratch assay of wound healing,
wound closure was delayed in AQP3-deficient keratinocytes,
with reduced cell protrusions seen at the wound edge. These
results suggested the involvement of AQP3-facilitated water
transport in keratinocyte migration, perhaps, as found for
AQP1 in endothelial cells, by increasing water influx into
protruding lamellipodia at the leading edge of migrating cells.
The motivation for investigating the involvement of AQP3
in keratinocyte proliferation were the observations of
defective proliferation of corneal epithelial cells in AQP3
deficiency resulting in delayed corneal wound healing
(Levin and Verkman, 2006), and defective proliferation in
AQP3-deficient colonocytes resulting in severe colitis in
experimental models of colitis (Thiagarajah et al., 2007).
Experiments using AQP3-null mice and human keratinocyte
cultures indicated impaired wound-induced cell proliferation
in AQP3 deficiency during wound repair (Figure 2c).
Epidermal growth factor-induced cell proliferation was
reduced in AQP3-deficient keratinocytes, with impaired
p38 mitogen-activated protein kinase cell signaling. Glycerol
supplementation restored the impairment in cell proliferation
during wound healing, supporting the involvement of AQP3-
facilitated glycerol transport in keratinocyte proliferation.
These data suggest the possibility of pharmacological
modulation of AQP3 to accelerate wound healing in
traumatic, burn, and other forms of injury.
Our initial study also found delayed barrier recovery after
tape stripping in AQP3-null mice (Hara et al., 2002). Oral
glycerol administration corrected the impairment in barrier
recovery, which was suggested to involve improved biosyn-
thetic function (Hara and Verkman, 2003). The more recent
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studies suggest the possible involvement of AQP3-facilitated
cell proliferation in epidermal barrier function.
Skin tumorigenesis
At least 13 different tumor cell types have been found to
express various AQPs, with AQP expression correlating with
tumor aggressiveness in some tumor types where studied, such
as AQP4 and malignant astroglioma (reviewed by Verkman
et al., 2008). AQP-facilitated water transport is involved in
tumor angiogenesis (Saadoun et al., 2005a), as mentioned
above, as well as in the migration, invasiveness, and metastatic
potential of tumor cells (Hu and Verkman, 2006).
Our motivation for studying the possible involvement of
AQP3 in skin tumorigenesis was the strong overexpression of
AQP3 in basal cells in human skin squamous cell carcinomas
(Figure 3a), and the role of AQP3 in proliferation of
keratinocytes during wound healing described above. In
experiments to address the role of AQP3 on skin tumori-
genesis, we discovered that AQP3-null mice do not develop
skin tumors following exposure to a tumor initiator and
phorbol ester promoter, a well-established multistage carcino-
genesis model (Yuspa et al., 1996), whereas under the same
conditions wild-type mice developed multiple tumors (Figure
3b) (Hara-Chikuma and Verkman, 2008b). Strong expression
of AQP3 was found in papilloma cells, which colocalized with
the proliferation marker keratin-14, but not with differentiation
markers, similar to human squamous cell carcinoma.
Studies to establish the cellular mechanisms responsible
for AQP3-dependent tumorigenesis, using live mice and
keratinocyte cell cultures, showed greatly impaired promo-
ter-induced cell proliferation in AQP3-deficient and knock-
down keratinocytes (Figure 3c). Comparable initiator-
induced apoptotic response and promoter penetration into
the epidermis were found in the wild-type and AQP3-null
epidermis, excluding differences in the initiation step or
promoter exposure as accounting for the differences in
tumorigenesis and cell proliferation. Epidermal differentiation
was similar in the wild-type and AQP3-null epidermis under
basal conditions and after promoter application. These results
suggest that impaired 12-O-tetradecanoylphorbol-13-acetate-
induced cell proliferation in AQP3 deficiency is responsible
for the absence of papillomas. Our data did not verify the
proposed involvement of AQP3 in keratinocyte differentia-
tion based on prior indirect evidence (Zheng and Bollinger
Bollag, 2003).
Analysis of mechanism showed reduced epidermal cell
glycerol, its metabolite glycerol-3-phosphate, and ATP in
AQP3 deficiency, without impairment of mitochondrial
function (Hara-Chikuma and Verkman, 2008b). Bollag et al.
(2007) recently reported evidence that AQP3 participates
with phospholipase-D in a glycerol–phosphatidylglycerol-
signalling module, although we found little difference in lipid
composition between wild-type and AQP3-null epidermis.
Further, the functional relevance of an AQP3–phospholipid-D
module is unclear because glycerol is freely diffusible. In
primary keratinocyte cultures, glycerol supplementation
corrected the defects in keratinocyte proliferation and redu-
ced ATP generation, providing evidence for the involvement
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Figure 2. Delayed wound healing with decreased keratinocyte proliferation and migration in AQP3-null mice. (a) In vivo wound-healing assay. Two
full-thickness punch biopsies (diameter 5 mm) were created on the backs of wild-type (þ /þ ) and AQP3-null (/) mice. The wound area was measured daily.
The percentage of initial wound area (SEM, n¼5, Po0.01 at 1–8 days). (b) Transwell cell migration assay (SEM, n¼ 6, *Po0.01). The bottom chamber
contained 10% or 1% fetal bovine serum. (c) (Left) Bromodeoxyuridine staining during wound closure in control and RNA interference-knockdown human
keratinocyte cultures. Bar¼ 50mm. (Right) The percentage of bromodeoxyuridine-positive cells within 250 mm of the wound margin (SEM, n¼ 4, *Po0.01
for control vs RNA interference). Adapted from Hara-Chikuma and Verkman (2008a) with kind permission of Springer Science & Business Media.
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of AQP3-facilitated glycerol transport in ATP generation and
keratinocyte proliferation. Further studies revealed correla-
tions between cell proliferation, and ATP and glycerol
concentrations. Oral glycerol administration also corrected
the impaired epidermal proliferative response in AQP3-null
mice epidermis.
Although ATP is thought to be the major energy source in
the epidermis as well as in tumor formation (Moreno-Sa´nchez
et al., 2007), the detailed metabolic pathways of ATP
production/synthesis in the epidermis have not been estab-
lished, nor has the role of glycerol metabolism, which is quite
tissue-specific (Brisson et al., 2001), been explained. The
expression of glycerol kinase, which catalyzes the phosphor-
ylation of glycerol to yield glycerol-3-phosphate, has not
been determined in epidermis. Studies are much needed to
elucidate the precise metabolic pathways in epidermal cells
linking glycerol and ATP generation.
From these findings, we proposed that AQP3-facilitated
glycerol transport is an important determinant of epidermal
cell proliferation and tumorigenesis by a novel mechanism in
which glycerol is a key regulator of cellular ATP energy.
Tumor-committed cells generally have an aggressive energy
metabolic profile, allowing them to compete with surround-
ing cells, proliferate, and form characteristic structure. The
remarkable resistance to skin tumorigenesis in AQP3
deficiency provides a rational basis for AQP3 inhibition/
suppression in the therapy of skin and possibly other cancers
associated with overexpression of aquaglyceroporins.
AQP3 IN SKIN DISEASES
Altered AQP3 expression has been found in a variety of skin
diseases. Immunostaining showed AQP3 expression in
Langerhans cell, dendritic cells, macrophages, neutrophils,
and eosinophils in erythema toxicum neonatorum, as
well as in epidermal keratinocytes, suggesting involvement
of AQP3 in the skin immune system at birth (Marchini et al.,
2003). Increased AQP3 transcript and protein expression
was found in atopic eczema (Olsson et al., 2006), with the
authors suggesting that increased AQP3 contributed to water
loss and dry skin. Perhaps increased AQP3 promotes
hyperproliferation of immature keratinocytes, resulting in
abnormal barrier function. AQP3 expression was absent in
epidermal spongiosis associated with eczema (Boury-Jamot
et al., 2006), with the authors suggesting a possible relation-
ship between absence of AQP3 and intercellular edema.
Whether AQP3 expression is altered in uninvolved skin in
diseased subjects was not measured, but is unlikely. As
shown above, AQP3 is expressed strongly in skin squamous
cell carcinomas, suggesting involvement of AQP3-facilitated
glycerol transport in cell proliferation during tumorigenesis
(Hara-Chikuma and Verkman, 2008b). A human kerato-
carcinoma cell line has also been found to express AQP3
(Nakakoshi et al., 2006). Whether altered AQP3 expression is
involved in a significant way in the pathophysiology of
skin diseases remains to be established. Changes in AQP3
expression may represent only secondary responses to
various disease processes.
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followed by multiple applications of the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, for 20 weeks (9–12 mice per group). (c) Impaired
epidermal cell proliferation in AQP3-deficient epidermis. The percentage of bromodeoxyuridine-positive cells in epidermal basal layer following vehicle
or four 12-O-tetradecanoylphorbol-13-acetate applications (TPA) (SEM, n¼ 4, *Po0.01). Adapted from Hara-Chikuma and Verkman (2008b).
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Several studies have shown regulated AQP3 expression in
keratinocytes. Hyperosmolarity increased AQP3 expression
by more than twofold in human keratinocyte cultures
(Sugiyama et al., 2001). Retinoic acid, a known regulator of
keratinocyte proliferation and differentiation, increased
AQP3 gene expression by B2-fold after 2 hours in the same
culture system (Cao et al., 2008; Belleme`re et al., 2008).
Phorbol ester application to mouse epidermis in vivo
increased AQP3 protein expression by 10-fold by 4 hours,
which was followed by a strong hyperproliferative response
(Hara-Chikuma and Verkman, 2008b). Although relevance of
these observations to skin physiology and disease pathogen-
esis is not known at this time, the ability to regulate
keratinocyte AQP3 expression suggests the possibility of
developing pharmacological agents to alter AQP3 expression
(or function) for treatment of skin diseases associated with
abnormal proliferation or water homeostasis.
SUMMARY AND PERSPECTIVE
Phenotype analysis of AQP3-null mice supports several
distinct roles of AQP3 in keratinocyte biology (Figure 4).
AQP3-facilitated water transport is involved in cell migration,
accelerating healing of cutaneous wounds. AQP3-facilitated
glycerol transport is involved not only in skin hydration and
elasticity, based on the humectant properties of glycerol, but
also in cell proliferation. We propose AQP3-facilitated
glycerol transport to be of central importance in generating
ATP, which facilitates the cell growth and tumorigenesis.
AQP3 may serve other functions in keratinocytes as well,
based perhaps on AQP3 protein–protein interactions.
Although there remain many basic mechanistic questions
about the involvement of AQP3 in cell proliferation and the
relevance of AQP3 to human skin diseases, the available data
suggest interesting new possibilities for clinical therapies.
AQP3 modulation by topical drugs may be of benefit in a
variety of common skin disorders associated with epidermal
hyperproliferation, such as skin carcinogenesis, psoriasis and
atopic dermatitis, and repair of burn and other wounds.
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